Zobrazeno 1 - 10
of 127
pro vyhledávání: '"James Aisenberg"'
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
The 2-D Tucker search problem is shown to be PPA-hard under many-one reductions; therefore it is complete for PPA. The same holds for k-D Tucker for all k ≥ 2 . This corrects a claim in the literature that the Tucker search problem is in PPAD.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbd97991d685fcf890e257d594b476b2
https://hdl.handle.net/2117/177608
https://hdl.handle.net/2117/177608
Autor:
Stuart J. Connolly, Martina Brueckmann, Jennifer M. Kolb, Prapti Chatterjee-Murphy, Paul A. Reilly, James Aisenberg, John Ilgenfritz, Jay Desai, Michael D. Ezekowitz, Kathryn Friedman Flack, Lars Wallentin
Publikováno v:
Digestive Diseases and Sciences. 63:1878-1889
Different oral anticoagulants may be associated with gastrointestinal bleeding (GIB) from different locations or mucosal lesions. We aimed to test this hypothesis. Two blinded gastroenterologists independently analyzed source documents from the rando
Autor:
Stuart J. Connolly, Martina Brueckmann, Kathryn Friedman Flack, Lars Wallentin, Salim Yusuf, James Aisenberg, Michael D. Ezekowitz, Jay Desai, Prapti Chatterjee, Paul A. Reilly, John Ilgenfritz, Jennifer M. Kolb
Publikováno v:
Clinical Gastroenterology and Hepatology. 15:682-690
Background & Aims Gastrointestinal (GI) bleeding in patients receiving anticoagulation agents can be caused by occult malignancies. We investigated the proportions and features of major GI bleeding (MGIB) events related to occult GI cancers in patien
Autor:
Sam Schulman, James Aisenberg
Publikováno v:
Journal of the American College of Cardiology. 72:268-270
Autor:
Frederikus A. Klok, Joanne van Ryn, Paul A. Reilly, Amelie Elsaesser, James Aisenberg, Sake J van der Wall, Renato D. Lopes, Stephan Glund, Charles V. Pollack, Menno V. Huisman
Publikováno v:
Circulation, 139(6), 748-756
Background: Although dabigatran has a favorable risk-benefit profile compared with vitamin K antagonist therapy for venous thromboembolism and nonvalvular atrial fibrillation, major bleeding events, including gastrointestinal (GI) bleeding, may occur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4275ab7cbd73b19945c4f3d067fd01b
http://hdl.handle.net/1887/119556
http://hdl.handle.net/1887/119556
Autor:
James Aisenberg
Publikováno v:
The American Journal of Gastroenterology Supplements. 3:36-44
The Specific Direct Oral Anticoagulant Reversal Agents: Their Current Status and Future Place in Gastroenterology Practice
Publikováno v:
The American Journal of Gastroenterology Supplements. 3:13-21
Incidence and Clinical Presentation of Gastrointestinal Bleeding in Atrial Fibrillation Patients Taking Direct Oral Anticoagulants
Autor:
Kathryn Friedman Flack, Christian T. Ruff, Michele Mercuri, Eugene Braunwald, Youngsook Choi, Robert P. Giugliano, Elliott M. Antman, Prapti Chatterjee-Murphy, Francesco Nordio, Jeffrey I. Weitz, James Aisenberg
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 11
Background: The ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis In Myocardial Infarction) compared higher-dose edoxaban regimen (HD-ER) and lower-dose edoxaban regimen with well-
Autor:
Dan Atar, Elaine M. Hylek, Michael D. Ezekowitz, Freek W.A. Verheugt, John W. Eikelboom, Gregory Y.H. Lip, Christopher B. Granger, James Aisenberg, Jonathan L. Halperin, Deirdre A. Lane, Hans-Christoph Diener, Stefan H. Hohnloser, Jack Ansell, Paulus Kirchhof, Roland Veltkamp, Günter Breithardt
Publikováno v:
Diener, H-C, Aisenberg, J, Ansell, J, Atar, D, Breithardt, G, Eikelboom, J, Ezekowitz, M D, Granger, C B, Halperin, J L, Hohnloser, S H, Hylek, E M, Kirchhof, P, Lane, D A, Verheugt, F W A, Veltkamp, R & Lip, G Y H 2017, ' Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation : part 1 ', European Heart Journal, vol. 38, no. 12, pp. 852-859 . https://doi.org/10.1093/eurheartj/ehv643
European Heart Journal, 38, 12, pp. 852-859
European Heart Journal, 38, 852-859
European Heart Journal, 38, 12, pp. 852-859
European Heart Journal, 38, 852-859
Contains fulltext : 176976.pdf (Publisher’s version ) (Closed access) Patients with atrial fibrillation (AF) have a high risk of stroke and mortality, which can be considerably reduced by oral anticoagulants (OAC). Recently, four non-vitamin-K oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5513a1715266284cbdb0b432b74b9a46
https://www.ncbi.nlm.nih.gov/pubmed/26848149
https://www.ncbi.nlm.nih.gov/pubmed/26848149
Autor:
Roland Veltkamp, Paulus Kirchhof, Gregory Y.H. Lip, Hans-Christoph Diener, Jack Ansell, Christopher B. Granger, Dan Atar, Deirdre A. Lane, Günter Breithardt, Stefan H. Hohnloser, Michael D. Ezekowitz, Jonathan L. Halperin, James Aisenberg, John W. Eikelboom, Elaine M. Hylek, Freek W.A. Verheugt
Publikováno v:
Diener, H-C, Aisenberg, J, Ansell, J, Atar, D, Breithardt, G, Eikelboom, J, Ezekowitz, M D, Granger, C B, Halperin, J L, Hohnloser, S H, Hylek, E M, Kirchhof, P, Lane, D A, Verheugt, F W A, Veltkamp, R & Lip, G Y H 2017, ' Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation : part 2 ', European Heart Journal, vol. 38, no. 12, pp. 860-868 . https://doi.org/10.1093/eurheartj/ehw069
European Heart Journal, 38, 860-868
European Heart Journal, 38, 12, pp. 860-868
European Heart Journal, 38, 860-868
European Heart Journal, 38, 12, pp. 860-868
Contains fulltext : 176977.pdf (Publisher’s version ) (Closed access) The choice of oral anticoagulant (OAC) for patients with atrial fibrillation (AF) may be influenced by individual clinical features or by patterns of risk factors and comorbiditi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2c7b4e8f9ecdb77c61a8816c51849d
https://vbn.aau.dk/da/publications/35f932d8-b027-45a1-9042-6692c2149aaa
https://vbn.aau.dk/da/publications/35f932d8-b027-45a1-9042-6692c2149aaa